Deployable Bistable Auxetic Expandable Interbody Spacer

USPTO published patent application US20260090894A1 disclosing a deployable bistable auxetic expandable interbody spacer for spinal applications. The invention by Troxell, Paul, and Johnson enables medical implants to transition between stable planar and 3D configurations. Application No. 18899689 was filed September 27, 2024, and published April 2, 2026.

Reverse Shoulder Glenoid Baseplate System

The USPTO published patent application US20260090893A1 for a reverse shoulder system including a glenoid baseplate with a stem featuring a central channel within the sidewall. The longitudinal axis of the glenoid baseplate is angled relative to the stem axis and is not perpendicular to it. Inventors are Donald E. Running, Robert J. Ball, and Jason Slone. Filing date was December 5, 2025.

Magnetic Knee Prosthesis System

USPTO published patent application US20260090892A1 filed by inventor James M. Jackson for a magnetic knee prosthesis system using repulsive magnetic forces between femoral and tibial components to potentially improve joint function. The application, filed December 9, 2025 under Application No. 19414239, covers A61F classifications related to orthopedic knee implants.

Patient-specific spinal implant design from image data

USPTO published patent application US20260090891A1 for patient-specific spinal implant design methodology. Invented by Michael J. Cordonnier, the method uses image data of the spine to measure geometric characteristics, applies mathematical rules, and generates 3D implant geometry for additive manufacturing. The application (No. 19321091) was filed September 5, 2025 and published April 2, 2026.

Shoulder prosthesis anchoring device with baseplate and central pin

USPTO published patent application US20260090890A1 for a shoulder prosthesis anchoring device in reverse configuration. The application claims a baseplate with a central pin featuring an inner duct with helical cavity. Inventors are Andrea Rosa, Francesco Siccardi, and Massimiliano Bernardoni. Application No. 19114921 was filed September 28, 2023.

Tibial augment block patent

USPTO published patent application US20260090889A1 for a tibial augment block invented by Ting DENG, Qing LEI, Zhuo ZHANG, and Song CHEN. The patent covers an arc-shaped insert with a connecting plate for tibial osteotomy procedures, including a connecting hole at a specified angle and a connector mechanism.

Belt for Applying Pressure to a Bodily Organ - Tricuspid Valve Regurgitation Treatment

The USPTO published patent application US20260090888A1 by Muffin Incorporated for a belt or band device designed to treat tricuspid valve regurgitation. The invention includes heat-set configurations to decrease the tricuspid annulus when deployed around the atrioventricular groove, along with tensioning sutures for cinching and force distribution structures. Application was filed December 8, 2025.

Quinoline cGAS Antagonist Solid Forms and Salts

The USPTO published patent application US20260092048A1 for solid forms and salts of a quinoline cGAS antagonist compound, filed by inventors Jian Qiu, Qi Wei, Heping Shi, Lijun Sun, and Zhijian Chen (Application No. 19316546, filed September 2, 2025). The application discloses the compound's cGAS antagonist properties, methods of preparation, pharmaceutical compositions, and use in medical therapy.

CFTR Modulator Patent, Pharmaceutical Compositions, Treatment Methods

The USPTO published patent application US20260092047A1 disclosing CFTR (Cystic Fibrosis Transmembrane Conductance Regulator) modulator compounds of Formula (I), their pharmaceutical compositions, methods of treating cystic fibrosis, and processes for making the modulators. The application also covers solid state forms of Compound 1 and salts and solvates thereof. The application was filed on May 13, 2025, with Application No. 19206359.

Quinoline Butenamide Maleate Salts for EGFR Cancer Treatment

The USPTO published patent application US20260092046A1 covering maleate salt forms of a quinoline-based butenamide compound designed to target epidermal growth factor receptor (EGFR) family kinases for cancer treatment. Invented by Quinhong Lu and colleagues, the application discloses crystalline forms, preparation methods, and pharmaceutical compositions. The patent application was filed on May 5, 2025, and published on April 2, 2026.